- NEWS IN BRIEF
Sanofi buys Inhibrx and drug for alpha-1 antitrypsin deficiency for US$1.7 billion
Access options
Nature Reviews Drug Discovery 23, 163 (2024)
doi: https://doi.org/10.1038/d41573-024-00031-5
Nature Reviews Drug Discovery 23, 163 (2024)
doi: https://doi.org/10.1038/d41573-024-00031-5